Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants

Clinical trial NCT05056246 · COMPLETED

Trial details

NCT number: NCT05056246
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2021-09-10
Primary completion: 2022-04-08
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.